BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
sequent scientific ltd. stock

SEQUENT SCIENTIFIC LTD. Share Price

189.7 5.25 (2.84%)
Dec 13 2024 03:30 PM Pharmaceuticals NSE: SEQUENT

SEQUENT SCIENTIFIC LTD. Share Price Update

As of the latest trading session, SEQUENT SCIENTIFIC LTD. share price is currently at 189.7, which is up by 5.25 from its previous closing. Today, the stock has fluctuated between 178.50 and 192.00. Over the past year, SEQUENT SCIENTIFIC LTD. has achieved a return of 53.31 %. In the last month alone, the return has been -10.57 %. Read More...

SEQUENT SCIENTIFIC LTD. Performance

Day Range

Low178.50 High192.00
189.70

52 Week Range

Low 92.05 High 240.70
189.70

SEQUENT SCIENTIFIC LTD. Share Price

14345

512529

SEQUENT

img img img img
No Data Available

Open Price

181.10

Prev. Close

184.44

Volume (Shares)

265597.00

Total traded value

503.83

Upper Circuit

193.66

Lower Circuit

175.21

Note: The current prices & values are delayed, Login to your account for live updates.

SEQUENT SCIENTIFIC LTD. Fundamentals


(Standalone)

Market Cap (Cr) 4731.75
PE Ratio (TTM) 271.40
Book Value / Share 44.29
Beta 1.05
ROE 0.22%
EPS (TTM) 0.80
Dividend Yield 0.00%
Net Profit Qtr (Cr) 4.26

SEQUENT SCIENTIFIC LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 41.99
Operating Expense 47.21
Net Profit 4.26
Net Profit Margin (%) 10.14
Earnings Per Share (EPS) 0.17
EBITDA 9.53
Effective Tax Rate (%) 33.54
Particulars JUN 2024 (Values in Cr)
Revenue 57.67
Operating Expense 62.46
Net Profit 4.50
Net Profit Margin (%) 7.80
Earnings Per Share (EPS) 0.18
EBITDA 8.86
Effective Tax Rate (%) 25.61
Particulars MAR 2024 (Values in Cr)
Revenue 36.77
Operating Expense 45.65
Net Profit 3.76
Net Profit Margin (%) 10.22
Earnings Per Share (EPS) 0.15
EBITDA 7.21
Effective Tax Rate (%) 8.29
Particulars DEC 2023 (Values in Cr)
Revenue 42.21
Operating Expense 49.55
Net Profit 4.58
Net Profit Margin (%) 10.85
Earnings Per Share (EPS) 0.18
EBITDA 9.29
Effective Tax Rate (%) 24.79
Particulars SEP 2023 (Values in Cr)
Revenue 49.12
Operating Expense 60.38
Net Profit -0.92
Net Profit Margin (%) -1.87
Earnings Per Share (EPS) -0.04
EBITDA 2.16
Effective Tax Rate (%) 34.28
Particulars MAR 2024 (Values in Cr)
Revenue 168.52
Operating Expense 208.48
Net Profit 0.63
Net Profit Margin (%) 0.37
Earnings Per Share (EPS) 0.03
EBITDA 13.07
Effective Tax Rate (%) 373.91
Particulars MAR 2023 (Values in Cr)
Revenue 222.69
Operating Expense 260.67
Net Profit -6.08
Net Profit Margin (%) -2.73
Earnings Per Share (EPS) -0.24
EBITDA 1.87
Effective Tax Rate (%) 37.64
Particulars MAR 2022 (Values in Cr)
Revenue 219.63
Operating Expense 231.58
Net Profit 14.80
Net Profit Margin (%) 6.73
Earnings Per Share (EPS) 0.60
EBITDA 26.89
Effective Tax Rate (%) 5.67
Particulars MAR 2021 (Values in Cr)
Revenue 265.46
Operating Expense 241.97
Net Profit 32.11
Net Profit Margin (%) 12.09
Earnings Per Share (EPS) 1.30
EBITDA 52.70
Effective Tax Rate (%) 21.44
Particulars MAR 2020 (Values in Cr)
Revenue 227.33
Operating Expense 219.09
Net Profit 21.34
Net Profit Margin (%) 9.38
Earnings Per Share (EPS) 0.88
EBITDA 36.80
Effective Tax Rate (%) 6.44
Particulars MAR 2024 (Values in Cr)
Book Value / Share 26.32
ROE % -3.09
ROCE % 0.45
Total Debt to Total Equity 0.69
EBITDA Margin 4.88
Particulars MAR 2023 (Values in Cr)
Book Value / Share 28.01
ROE % -9.04
ROCE % -3.52
Total Debt to Total Equity 0.58
EBITDA Margin 1.14
Particulars MAR 2022 (Values in Cr)
Book Value / Share 27.50
ROE % 6.31
ROCE % 6.57
Total Debt to Total Equity 0.45
EBITDA Margin 8.51
Particulars MAR 2021 (Values in Cr)
Book Value / Share 29.30
ROE % 13.98
ROCE % 14.62
Total Debt to Total Equity 0.44
EBITDA Margin 15.54
Particulars MAR 2020 (Values in Cr)
Book Value / Share 27.66
ROE % 10.17
ROCE % 10.78
Total Debt to Total Equity 0.48
EBITDA Margin 15.30
Particulars MAR 2024 (Values in Cr)
Book Value / Share 43.59
ROE % 0.22
ROCE % 0.52
Total Debt to Total Equity 0.03
EBITDA Margin 8.75
Particulars MAR 2023 (Values in Cr)
Book Value / Share 42.43
ROE % -0.58
ROCE % -0.68
Total Debt to Total Equity 0.02
EBITDA Margin 0.84
Particulars MAR 2022 (Values in Cr)
Book Value / Share 41.55
ROE % 1.43
ROCE % 1.65
Total Debt to Total Equity 0.01
EBITDA Margin 12.24
Particulars MAR 2021 (Values in Cr)
Book Value / Share 41.45
ROE % 3.27
ROCE % 4.34
Total Debt to Total Equity 0.02
EBITDA Margin 19.85
Particulars MAR 2020 (Values in Cr)
Book Value / Share 35.68
ROE % 2.23
ROCE % 2.79
Total Debt to Total Equity 0.04
EBITDA Margin 16.19
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 69.83
Total Assets 1540.38
Total Liabilities 1540.38
Total Equity 712.95
Share Outstanding 249433495
Price to Book Ratio 2.65
Return on Assets (%) -2.32
Return on Capital (%) -3.08
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 41.74
Total Assets 1529.12
Total Liabilities 1529.12
Total Equity 749.19
Share Outstanding 249433495
Price to Book Ratio 1.71
Return on Assets (%) -7.92
Return on Capital (%) -10.56
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 59.25
Total Assets 1450.97
Total Liabilities 1450.97
Total Equity 740.10
Share Outstanding 248370995
Price to Book Ratio 3.22
Return on Assets (%) 2.82
Return on Capital (%) 3.88
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 56.19
Total Assets 1392.55
Total Liabilities 1392.55
Total Equity 776.31
Share Outstanding 248370995
Price to Book Ratio 5.81
Return on Assets (%) 6.85
Return on Capital (%) 9.53
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 75.82
Total Assets 1462.64
Total Liabilities 1462.64
Total Equity 731.84
Share Outstanding 248370995
Price to Book Ratio 2.18
Return on Assets (%) 4.77
Return on Capital (%) 6.79
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.95
Total Assets 1187.59
Total Liabilities 1187.59
Total Equity 1087.22
Share Outstanding 249433495
Price to Book Ratio 2.65
Return on Assets (%) 0.05
Return on Capital (%) 0.05
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.17
Total Assets 1122.77
Total Liabilities 1122.77
Total Equity 1058.36
Share Outstanding 249433495
Price to Book Ratio 1.71
Return on Assets (%) -0.54
Return on Capital (%) -0.56
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 12.88
Total Assets 1124.23
Total Liabilities 1124.23
Total Equity 1041.08
Share Outstanding 248370995
Price to Book Ratio 3.22
Return on Assets (%) 1.31
Return on Capital (%) 1.4
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.74
Total Assets 1102.12
Total Liabilities 1102.12
Total Equity 1029.51
Share Outstanding 248370995
Price to Book Ratio 5.81
Return on Assets (%) 2.91
Return on Capital (%) 3.1
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 3.71
Total Assets 997.37
Total Liabilities 997.37
Total Equity 886.21
Share Outstanding 248370995
Price to Book Ratio 2.18
Return on Assets (%) 2.13
Return on Capital (%) 2.33
Particulars MAR 2024 (Values in Cr)
Net Income -54.64
Cash from Operations 44.65
Cash from Investing -5.92
Cash from Financing -1.43
Net change in Cash 23.23
Free Cash Flow 75.45
Particulars MAR 2023 (Values in Cr)
Net Income -137.65
Cash from Operations 31.45
Cash from Investing -64.95
Cash from Financing 32.22
Net change in Cash -15.92
Free Cash Flow 117.63
Particulars MAR 2022 (Values in Cr)
Net Income 52.93
Cash from Operations 57.36
Cash from Investing -95.56
Cash from Financing 67.25
Net change in Cash 2.28
Free Cash Flow 89.82
Particulars MAR 2021 (Values in Cr)
Net Income 145.45
Cash from Operations 158.54
Cash from Investing 9.64
Cash from Financing -138.75
Net change in Cash -14.35
Free Cash Flow 211.37
Particulars MAR 2020 (Values in Cr)
Net Income 94.07
Cash from Operations 127.18
Cash from Investing -72.27
Cash from Financing -42.75
Net change in Cash 0.30
Free Cash Flow 167.90
Particulars MAR 2024 (Values in Cr)
Net Income -0.23
Cash from Operations -29.19
Cash from Investing 5.47
Cash from Financing 22.31
Net change in Cash 0.84
Free Cash Flow -19.66
Particulars MAR 2023 (Values in Cr)
Net Income -9.74
Cash from Operations 38.44
Cash from Investing -50.70
Cash from Financing 0.24
Net change in Cash -12.71
Free Cash Flow 47.30
Particulars MAR 2022 (Values in Cr)
Net Income 15.69
Cash from Operations 11.11
Cash from Investing -4.24
Cash from Financing 7.24
Net change in Cash 12.36
Free Cash Flow 17.56
Particulars MAR 2021 (Values in Cr)
Net Income 43.44
Cash from Operations 19.09
Cash from Investing 16.55
Cash from Financing -21.32
Net change in Cash -2.43
Free Cash Flow 28.61
Particulars MAR 2020 (Values in Cr)
Net Income 22.81
Cash from Operations 32.39
Cash from Investing -17.68
Cash from Financing -10.71
Net change in Cash 1.80
Free Cash Flow 37.78
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.57 37.68 3.57 502.48 37.54 / 77.70
BLISS GVS PHARMA LTD 173.80 21.75 1.81 1830.67 92.25 / 175.80
CIPLA LTD 1446.35 25.30 4.11 116809.04 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 406.80 141.25 4.12 1197.25 145.00 / 440.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.57 57.02 11.14 502.48 37.54 / 77.70
AMRUTAJAN HEALTH LTD 751.60 45.72 7.29 2172.92 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6636.00 128.88 24.42 16590.00 4050.15 / 8139.85
BLISS GVS PHARMA LTD 173.80 22.66 1.78 1830.67 92.25 / 175.80

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 189.90
  • 26 Days 197.80
  • 10 Days 193.80
  • 50 Days 201.20
  • 12 Days 194.30
  • 100 Days 182.20
  • 20 Days 196.90
  • 200 Days 147.80
186.46
PIVOT
First Resistance 189.93
Second Resistance 195.41
Third Resistance 198.88
First Support 180.98
Second Support 177.51
Third Support 172.03
RSI 39.16
MACD -3.43
Commodity Channel Index (CCI) -138.10
ADX 27.05
Williams % R -95.03

Over 1 Month

down

-10.57

Over 3 Months

down

5.56

Over 6 Months

down

47.95

Over 1 Year

down

53.31

Over 3 Years

down

1.67

Over 5 Years

down

22.94

SEQUENT SCIENTIFIC LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

SEQUENT SCIENTIFIC LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
30.79
Promoter Holdings
52.76
FII
6.44
DII
9.99
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Ca Harbor Investments Shareholding of Promoter and Promoter Group 1.31680103E8 52.76
Quant Mutual Fund - Quant Small Cap Fund Public Shareholding 1.7298366E7 6.93
Ashoka Whiteoak Icav - Ashoka Whiteoak India Oppor Public Shareholding 4078604.0 1.63

SEQUENT SCIENTIFIC LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2021-09-08 0.5 Final 2021-09-10 Equity shares 2019-08-21 0.2 Final 2019-08-23 Equity shares 2017-11-20 0.2 Interim 2017-11-21 Equity shares 2011-09-16 1.5 Final 2011-09-20 Equity shares 2010-09-23 2.0 Final 2010-09-27 Equity shares 2009-09-02 1.0 Final 2009-09-04 Equity shares 2008-09-11 1.0 Final 2008-09-15 Equity shares 2007-09-13 1.0 Final 2007-09-17 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date
2016-02-25 10.0 2.0 2016-02-26

Learn More About Stocks

About SEQUENT SCIENTIFIC LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by SEQUENT SCIENTIFIC LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Sequent Scientific Ltd?

Answer Field

The share price of Sequent Scientific Ltd for NSE is ₹ 189.7 and for BSE is ₹ 189.

What is the Market Cap of Sequent Scientific Ltd?

Answer Field

The market cap of Sequent Scientific Ltd for NSE is ₹ 47,31.75 Cr. and for BSE is ₹ 47,14.29 Cr. as of now.

What is the 52 Week High and Low of Sequent Scientific Ltd?

Answer Field

The 52 Week High and Low of Sequent Scientific Ltd for NSE is ₹ 240.70 and ₹ 92.05 and for BSE is ₹ 240.90 and ₹ 91.85.

How to Buy Sequent Scientific Ltd share?

Answer Field

You can trade in Sequent Scientific Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Sequent Scientific Ltd?

Answer Field

The 1 year returns on the stock has been 53.31%.

What is the Current Share Price of Sequent Scientific Ltd?

Answer Field

Sequent Scientific Ltd share price is for NSE ₹ 189.7 & for BSE ₹ 189 as on Dec 13 2024 03:30 PM.

What is the Market Cap of Sequent Scientific Ltd Share?

Answer Field

The market cap of Sequent Scientific Ltd for NSE ₹ 47,31.75 & for BSE ₹ 47,14.29 as on Dec 13 2024 03:30 PM.

What is the P/E Ratio of Sequent Scientific Ltd Share?

Answer Field

As on Dec 13 2024 03:30 PM the price-to-earnings (PE) ratio for Sequent Scientific Ltd share is 271.40.

What is the PB ratio of Sequent Scientific Ltd Share?

Answer Field

As on Dec 13 2024 03:30 PM, the price-to-book (PB) ratio for Sequent Scientific Ltd share is 44.29.

How to Buy Sequent Scientific Ltd Share?

Answer Field

You can trade in Sequent Scientific Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Sequent Scientific Ltd Share on Bajaj Broking App?

Answer Field

To buy Sequent Scientific Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sequent Scientific Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader